Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 91-2054035

RIVKIN CENTER FOR OVARIAN CANCER

Tax-exempt · SEATTLE, WA 98144

Financials

$1.3M$1.4M2023$1.7M$1.7M2024
Revenue Expenses · by fiscal year end
Financials of RIVKIN CENTER FOR OVARIAN CANCER by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$1,700,018$1,678,303$21,715$1,970,548$30,329$1,940,219
December 31, 2023990$1,284,232$1,404,009-$119,777$1,949,824$31,061$1,918,763
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$1,523,596
of which government grants
$103,500
Program service revenue
$157,825
Investment income
$7,357
Net gain from sales of assets
-$87
Net income from fundraising events
$11,240
Other revenue
$11,240

Expenses

Grants and similar amounts paid
$290,470
Compensation of officers, directors and key employees
$220,743
Other salaries and wages
$237,691
Salaries, compensation and benefits (total)
$521,961
Professional fundraising fees
$101,975
Legal fees
$11,273
Accounting fees
$58,235
Occupancy
$30,263
Travel
$638
Program services (functional)
$651,271
Management and general (functional)
$301,417
Fundraising (functional)
$725,615

Balance sheet and other

Total assets, start of year
$1,949,824
Total assets, end of year
$1,970,548
Total liabilities, end of year
$30,329
Net assets, end of year
$1,940,219
Publicly traded securities
$145,750
Net assets without donor restrictions
$1,549,825
Net assets with donor restrictions
$390,394
Gross receipts
$1,790,856
Employees
8
Volunteers
50
Year formed
1996
State of legal domicile
WA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
MOLLY O'CONNORCEO
Officer
40$161,600$24,082
PAULINE MIDDLEHURSTDEVELOPMENT DIRECTOR (UNTIL 4/2024)
Officer
40$29,586$5,475
MELISSA RIVKINPRESIDENT
Trustee or director, Officer
1$0$0
AMY SINGVICE PRESIDENT
Trustee or director, Officer
1$0$0
ALEX SMITHSECRETARY
Trustee or director, Officer
1$0$0
THOMAS BROWNMEMBER
Trustee or director
1$0$0
EVA CORETSMEMBER
Trustee or director
1$0$0
AUDREY COVNERMEMBER
Trustee or director
1$0$0
KRISTIN HAWESMEMBER
Trustee or director
1$0$0
BOB MAHLERMEMBER
Trustee or director
1$0$0
FERNANDA MUSAMEMBER
Trustee or director
1$0$0
KATERIE SCHEIMEMBER
Trustee or director
1$0$0
KATIE VAN KESSELMEMBER
Trustee or director
1$0$0
ANDREA REWITZ MIZERMEMBER (UNTIL 6/2024)
Trustee or director
1$0$0
990 for the year ended December 31, 2023: 14 people
NameTitleHours / weekCompensationOther / benefits
MOLLY O'CONNORCEO
Officer
40$161,565$21,416
PAULINE MIDDLEHURSTDEVELOPMENT DIRECTOR
Officer
40$86,469$8,536
MELISSA RIVKINPRESIDENT
Trustee or director, Officer
1$0$0
AMY SINGVICE PRESIDENT
Trustee or director, Officer
1$0$0
ALEX SMITHSECRETARY
Trustee or director, Officer
1$0$0
THOMAS BROWNMEMBER
Trustee or director
1$0$0
EVA CORETSMEMBER
Trustee or director
1$0$0
AUDREY COVNERMEMBER
Trustee or director
1$0$0
KRISTIN HAWESMEMBER
Trustee or director
1$0$0
FERNANDA MUSAMEMBER
Trustee or director
1$0$0
ANDREA REWITZ MIZERMEMBER
Trustee or director
1$0$0
KATERIE SCHEIMEMBER
Trustee or director
1$0$0
KATIE VAN KESSELMEMBER
Trustee or director
1$0$0
DANIEL VELJOVICHMEMBER (UNTIL 12/23)
Trustee or director
1$0$0

Address and contacts

Address (IRS master file)
1200 12TH AVE S STE 1110, SEATTLE, WA 98144-2776
In care of
% MOLLY OCONNER
Principal officer (990 for 2024)
MOLLY O'CONNOR, 1200 12TH AVE S STE 1110, SEATTLE, WA 98144
Signed the 990
MOLLY O'CONNOR, CEO
Phone
(206) 490-0847
Return prepared by
VINE DAHLEN PLLC

Mission

WE ENVISION A WORLD WHERE WOMEN LIVE LONGER AND HEALTHIER LIVES BECAUSE OVARIAN CANCER CAN BE PREVENTED, CAUGHT EARLY, OR CURED.

990 for the year ended December 31, 2024

Program accomplishments

  • THE RIVKIN CENTER'S PROGRAMMATIC WORK UNDERWENT DYNAMIC CHANGE IN 2024, AND EVEN BIGGER CHANGES ARE COMING FOR 2025.FOR THREE DECADES, THE RIVKIN CENTER'S SCIENTIFIC GRANT PROGRAM HAS USED A SEED-FUNDING APPROACH THAT LAUNCHES PROMISING NEW RESEARCH AND RESEARCHERS THROUGHOUT THE WORLD. AFTER PAUSING NEW GRANTS IN 2023, THE RIVKIN CENTER FUNDED TWO $75K PILOT STUDY AWARDS IN 2024. THE RIVKIN CENTER AND WASHINGTON STATE'S ANDY HILL CANCER RESEARCH ENDOWMENT (CARE) FUND ALSO CREATED A PUBLIC-PRIVATE PARTNERSHIP TO JOINTLY SUPPORT $1M IN OVARIAN CANCER RESEARCH IN WASHINGTON STATE. IN 2024, THE FIRST TWO GRANTS TOTALING $400K WERE AWARDED; $600K IN GRANTS WILL BE AWARDED IN 2025. BY THE END OF 2024, THE RIVKIN CENTER HAD RAISED ITS $500K IN PRIVATE MATCHING FUNDS. OVARIAN CANCER IS UNDERFUNDED BY FEDERAL FUNDING AGENCIES WHEN COMPARED TO OTHER CANCERS, DESPITE IT STILL HAVING NO UNIVERSAL SCREENING TOOL AND BEING THE DEADLIEST GYNECOLOGICAL CANCER. FOR EVERY DOLLAR INVESTED BY THE RIVKIN CENTER, OUR AWARDEES, ON AVERAGE, LEVERAGE ANOTHER $17.30 FROM OTHER FUNDING SOURCES TO FURTHER THEIR OVARIAN CANCER RESEARCH.
    Expenses $290,470 · grants $290,470
  • IN SEPTEMBER 2024, THE RIVKIN CENTER HOSTED THE 15TH BIENNIAL OVARIAN CANCER RESEARCH SYMPOSIUM, BRINGING TOGETHER NEARLY 250 RESEARCHERS AND CLINICIANS FROM 11 COUNTRIES WHO CAME TO LEARN ABOUT THE LATEST IN OVARIAN CANCER RESEARCH. THE EVENT HOSTED A SESSION WITH PATIENT ADVOCATES; SCIENTIFIC SESSIONS COVERED THE BIOLOGY OF OVARIAN CANCER, PREVENTION, EARLY DETECTION, & INTERCEPTION, EMERGING THERAPEUTICS, NOVEL IMMUNOTHERAPIES, AND HEALTHCARE DISPARITIES. ON APRIL 30, 2024, THE RIVKIN CENTER ENDED ITS EDUCATION PROGRAM FOCUSED ON OVARIAN AND BREAST CANCER EDUCATION AND RETURNED TO A SOLE FOCUS ON OVARIAN CANCER - BOTH RESEARCH GRANTS AND BETTER SUPPORT FOR THOSE DIAGNOSED WITH OVARIAN CANCER IN THE PACIFIC NORTHWEST. FROM JANUARY TO MARCH 2024 THE EDUCATION TEAM SUPPORTED 15 COLLEGE-CAMPUS WORKSHOPS AND EIGHT PUGET SOUND COMMUNITY WORKSHOPS. COMMUNITY WORKSHOPS WERE HELD IN COORDINATION WITH MERCY HOUSING, MARY'S PLACE, FAMILYWORKS, WASHINGTON RHINESTONE CLUB, SEATTLE JEWISH FESTIVAL AND HERZL NER TAMID AND REACHED PRIMARILY PARTICIPANTS WHO BELONG TO HISTORICALLY UNDER-RESOURCED/UNDERREPRESENTED GROUPS.
    Expenses $360,801 · revenue $157,825

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
91-2054035
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2001
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H30)
Assets (IRS master file)
$1,970,548
Income (IRS master file)
$1,790,856

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$1,700,018$1,678,303$1,970,548XML
990December 2023$1,284,232$1,404,009$1,949,824XML
990December 2022$1,484,984$1,297,053$2,071,817IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 91-2054035).

Questions about RIVKIN CENTER FOR OVARIAN CANCER

What is the EIN of RIVKIN CENTER FOR OVARIAN CANCER?
The employer identification number (EIN) of RIVKIN CENTER FOR OVARIAN CANCER is 91-2054035.
Is RIVKIN CENTER FOR OVARIAN CANCER tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2001.
Are donations to RIVKIN CENTER FOR OVARIAN CANCER tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does RIVKIN CENTER FOR OVARIAN CANCER file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of RIVKIN CENTER FOR OVARIAN CANCER due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did RIVKIN CENTER FOR OVARIAN CANCER last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of RIVKIN CENTER FOR OVARIAN CANCER?
The 990 for the year ended December 31, 2024 names MOLLY O'CONNOR.
Who are the officers and directors of RIVKIN CENTER FOR OVARIAN CANCER?
The 990 for the year ended December 31, 2024 lists 14 people; 2 received compensation from the organization, the highest $161,600 (MOLLY O'CONNOR, CEO).
How much revenue does RIVKIN CENTER FOR OVARIAN CANCER have?
On its 990 for the year ended December 31, 2024 it reported revenue of $1,700,018, expenses of $1,678,303 and total assets of $1,970,548 at year end.

Other nonprofits in SEATTLE

All nonprofits in SEATTLE · Washington · Medical research